Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
510.61
307.83
231.34
319.11
256.39
30.01
Shareholder's Funds
510.61
307.83
231.34
319.11
256.39
30.01
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
5.64
3.15
2.65
1.23
0.00
0.00
Secured Loans
5.64
3.15
2.65
1.23
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
20.63
13.11
14.78
18.04
15.2
15.27
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
20.63
13.11
14.78
18.04
15.20
15.27
Current Liabilities
Trade Payables
4.39
3.52
3.32
4.76
1.79
1.74
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
29.15
18.95
15.73
16.34
16.74
12.96
Total Liabilities
560.38
339.89
261.85
353.49
288.33
58.23
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
57.19
43.60
43.08
34.28
8.92
7.67
Less: Accumulated Depreciation
16.59
11.93
7.73
5.33
3.84
2.62
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
40.61
31.66
35.35
28.95
5.07
5.05
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
80.58
10.95
4.91
67.65
0.00
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
4.26
0.68
1.08
0.60
0.60
0.68
Total Non-Current Assets
125.45
43.30
41.34
97.21
5.68
5.73
Current Assets Loans & Advances
Current Investments
275.54
39.12
161.20
94.78
0.00
0.00
Inventories
0.00
0.00
0.00
0.00
0.00
0.00
Sundry Debtors
0.00
0.00
0.00
0.05
1.49
0.98
Cash and Bank
149.34
249.11
52.35
153.00
276.73
49.65
Other Current Assets
424.88
288.23
214.25
247.82
278.21
50.63
Short Term Loans and Advances
0.00
0.00
0.70
0.00
0.00
0.00
Total Current Assets
434.93
296.59
220.51
256.28
282.66
52.51
Net Current Assets (Including Current Investments)
405.78
277.64
204.78
239.94
265.91
39.55
Total Current Assets Excluding Current Investments
434.93
296.59
220.51
256.28
282.66
52.51
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
560.38
339.89
261.85
353.49
288.33
58.23
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
5.64
3.15
2.65
1.23
0.00
0.00
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
Compare Balance Sheet Results of 4D Molecular Therapeutics, Inc.
Figures in Million
Consolidated - Balance Sheet Results
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
510.61
154.49
356.12
230.51%
Shareholder's Funds
510.61
154.49
356.12
230.51%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
5.64
3.57
2.07
57.98%
Secured Loans
5.64
3.57
2.07
57.98%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
20.63
21.75
-1.12
-5.15%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
20.63
21.75
-1.12
-5.15%
Current Liabilities
Trade Payables
4.39
3.24
1.15
35.49%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
29.15
16.45
12.70
77.20%
Total Liabilities
560.38
192.69
367.69
190.82%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
57.19
15.45
41.74
270.16%
Less: Accumulated Depreciation
16.59
2.76
13.83
501.09%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
40.61
12.69
27.92
220.02%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
80.58
1.63
78.95
4,843.56%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
4.26
0.02
4.24
21,200.00%
Total Non-Current Assets
125.45
14.34
111.11
774.83%
Current Assets Loans & Advances
Current Investments
275.54
16.96
258.58
1,524.65%
Inventories
0
0
0.00
0.00%
Sundry Debtors
0
0
0.00
0.00%
Cash and Bank
149.34
154.47
-5.13
-3.32%
Other Current Assets
424.88
171.43
253.45
147.84%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
434.93
178.35
256.58
143.86%
Net Current Assets (Including Current Investments)
405.78
161.89
243.89
150.65%
Total Current Assets Excluding Current Investments
434.93
178.35
256.58
143.86%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
560.38
192.69
367.69
190.82%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
5.64
3.57
2.07
57.98%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Analysis not available as Data has been published for only 1 period
Annual - Other Long Term Liabilities
Analysis not available as Data has been published for only 1 period
Annual - Fixed Assets
Analysis not available as Data has been published for only 1 period
Annual - Investments
Analysis not available as Data has been published for only 1 period
Annual - Current Assets
Analysis not available as Data has been published for only 1 period






